UniProt Q9ELS8
Q9ELS8
Q9ELS8 (UniProt Q9ELS8): 24 experimental structures on GenesisL1. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q9ELS8
- Experimental structures
- 24
- Predicted models
- 0
Structures
24 records of Q9ELS8 in the MolNFT archive: 24 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2O8M | Crystal structure of the S139A mutant of Hepatitis C Virus NS3/4A protease | x-ray diffraction | A, B | — | — |
| 2O8M | Crystal structure of the S139A mutant of hepatitis C virus NS3/4A protease | x-ray diffraction | A, B | — | — |
| 2OBQ | Discovery of the HCV NS3/4A Protease Inhibitor SCH503034. Key Steps in Structure-Based Optimization | x-ray diffraction | A, C | — | — |
| 2OBQ | Discovery of the HCV NS3/4A protease inhibitor SCH503034. key steps in structure-based optimization | x-ray diffraction | A, C | — | — |
| 2OC0 | Structure of NS3 complexed with a ketoamide inhibitor SCh491762 | x-ray diffraction | A, C | — | — |
| 2OC0 | Structure of NS3 complexed with a ketoamide inhibitor SCH491762 | x-ray diffraction | A, C | — | — |
| 2OC1 | Structure of the HCV NS3/4A Protease Inhibitor CVS4819 | x-ray diffraction | A, C | — | — |
| 2OC1 | Structure of the HCV NS3/4A protease inhibitor CVS4819 | x-ray diffraction | A, C | — | — |
| 2OC7 | Structure of Hepatitis C Viral NS3 protease domain complexed with NS4A peptide and ketoamide… | x-ray diffraction | A, C | — | — |
| 2OC7 | Structure of hepatitis C viral NS3 protease domain complexed with NS4A peptide and ketoamide… | x-ray diffraction | A, C | — | — |
| 2OC8 | Structure of Hepatitis C Viral NS3 protease domain complexed with NS4A peptide and ketoamide… | x-ray diffraction | A, C | — | — |
| 2OC8 | Structure of hepatitis C viral NS3 protease domain complexed with NS4A peptide and ketoamide… | x-ray diffraction | A, C | — | — |
| 2OIN | crystal structure of HCV NS3-4A R155K mutant | x-ray diffraction | A, B | — | — |
| 2OIN | Crystal structure of HCV NS3-4A R155K muntant | x-ray diffraction | A, B | — | — |
| 3EYD | Structure of HCV NS3-4A Protease with an Inhibitor Derived from a Boronic Acid | x-ray diffraction | A, B, C, D | — | — |
| 3EYD | Structure of HCV NS3-4A protease with an inhibitor derived from a boronic acid | x-ray diffraction | A, B, C, D | — | — |
| 3KN2 | HCV NS3 Protease Domain with ketoamide inhibitor | x-ray diffraction | A, C | — | — |
| 3KN2 | HCV NS3 protease domain with ketoamide inhibitor | x-ray diffraction | A, C | — | — |
| 3KNX | HCV NS3 protease domain with P1-P3 macrocyclic ketoamide inhibitor | x-ray diffraction | A, B, C, D | — | — |
| 3KNX | HCV NS3 protease domain with P1-P3 macrocyclic ketoamide inhibitor | x-ray diffraction | A, B, C, D | — | — |
| 3LON | HCV NS3-4a protease domain with ketoamide inhibitor narlaprevir | x-ray diffraction | A, C | — | — |
| 3LON | HCV NS3-4A protease domain with ketoamide inhibitor narlaprevir | x-ray diffraction | A, C | — | — |
| 3LOX | HCV NS3-4a protease domain with a ketoamide inhibitor derivative of Boceprevir bound | x-ray diffraction | A, C | — | — |
| 3LOX | HCV NS3-4A protease domain with a ketoamide inhibitor derivative of boceprevir bound | x-ray diffraction | A, C | — | — |
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.